Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice

Dana Hoser, Christian Schön, Christoph Loddenkemper, Philipp Lohneis, Anja A. Kühl, Thomas Sommermann, Thomas Blankenstein, Gerald Willimsky

Blood (2018) 132 (9): 924–934.

https://doi.org/10.1182/blood-2018-02-834036

Published: 2018

Includes: Supplemental data

Journal Articles

Tumor Cell Proliferation (Ki-67 Index) Overcomes Cytology and Growth Pattern As Prognostic Factor in Mantle-Cell Lymphoma – Results from Randomized Trials of the European MCL Network

Eva Hoster, PhD, Andreas Rosenwald, MD, Francoise Berger, MD PhD, Heinz-Wolfram Bernd, Sylvia Hartmann, Christoph Loddenkemper, Thomas Barth, Nicole Brousse, Stefano Pileri, Grzegorz Rymkiewicz, Roman Kodet, Michael Unterhalt, MD, Johanna C. Kluin-Nelemans, Olivier Hermine, MD PhD, Wolfgang Hiddemann, MD PhD, Martin H. Dreyling, Wolfram Klapper, MD

Blood (2014) 124 (21): 2977.

https://doi.org/10.1182/blood.V124.21.2977.2977

Published: 2014

Journal Articles

Splenic proliferative lymphoid nodules distinct from germinal centers are sites of autoantigen stimulation in immune thrombocytopenia

Capucine Daridon, Christoph Loddenkemper, Simone Spieckermann, Anja A. Kühl, Abdulgabar Salama, Gerd R. Burmester, Peter E. Lipsky, Thomas Dörner

Blood (2012) 120 (25): 5021–5031.

https://doi.org/10.1182/blood-2012-04-424648

Published: 2012

Includes: Supplemental data

Journal Articles

Cell Proliferation (Ki-67) As Prognostic Marker in Mantle Cell Lymphoma.

Eva Hoster, Wolfram Klapper, Andreas Rosenwald, MD, Heinz-Wolfram Bernd, Sylvia Hartmann, Christoph Loddenkemper, Thomas F.E. Barth, Wolfgang Hiddemann, MD, PhD, Michael Unterhalt, Hanneke C. Kluin-Nelemans, Olivier Hermine, Martin Dreyling

Blood (2012) 120 (21): 2677.

https://doi.org/10.1182/blood.V120.21.2677.2677

Published: 2012

Journal Articles

Lack of Foxp3 + macrophages in both untreated and B16 melanoma-bearing mice

Christian T. Mayer, Anja A. Kühl, Christoph Loddenkemper, Tim Sparwasser

Blood (2012) 119 (5): 1314–1315.

https://doi.org/10.1182/blood-2011-11-392266

Published: 2012

Journal Articles

Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation

Stefan Schwartz, Maria Vergoulidou, Eckart Schreier, Christoph Loddenkemper, Mark Reinwald, Martin Schmidt-Hieber, Willy A. Flegel, Eckhard Thiel, Thomas Schneider

Blood (2011) 117 (22): 5850–5856.

https://doi.org/10.1182/blood-2010-12-325886

Published: 2011

Journal Articles

Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation

Kristina Allers, Gero Hütter, Jörg Hofmann, Christoph Loddenkemper, Kathrin Rieger, Eckhard Thiel, Thomas Schneider

Blood (2011) 117 (10): 2791–2799.

https://doi.org/10.1182/blood-2010-09-309591

Published: 2011

Journal Articles

Steady-state generation of mucosal IgA + plasmablasts is not abrogated by B-cell depletion therapy with rituximab

Henrik E. Mei, Daniela Frölich, Claudia Giesecke, Christoph Loddenkemper, Karin Reiter, Stefanie Schmidt, Eugen Feist, Capucine Daridon, Hans-Peter Tony, Andreas Radbruch, Thomas Dörner

Blood (2010) 116 (24): 5181–5190.

https://doi.org/10.1182/blood-2010-01-266536

Published: 2010

Includes: Supplemental data

Journal Articles

CD19 as Foreign Antigen Elicits a Specific T-Cell Response and Mediates Rejection of High Grade B-Cell Lymphoma In Mice

Frank Lehmann, Armin Gerbitz, MD, PhD, Christoph Loddenkemper, MD, PhD, Elisabeth Kremmer, PhD, Josef Mautner, PhD, Thomas Kammertöns, PhD, Georg Bornkamm, MD, PhD

Blood (2010) 116 (21): 4907.

https://doi.org/10.1182/blood.V116.21.4907.4907

Published: 2010

Journal Articles

Stromal Cross-Presentation and Host Interferon-γ Signaling and Are Required for Elimination of Antigen-Loss Variants of High-Grade B Cell Lymphomas: Implications for Adoptive T Cell Therapy

Armin Gerbitz, MD, PhD, Madhusudhanan Sukumar, PhD, Florian Helm, Andrea Wilke, Christian Friese, Cornelia Fahrenwaldt, Frank Lehmann, Christoph Loddenkemper, MD, PhD, Thomas Kammertöns, PhD, Josef Mautner, PhD, Thomas Blankenstein, PhD, Georg Bornkamm, MD, PhD

Blood (2010) 116 (21): 3927.

https://doi.org/10.1182/blood.V116.21.3927.3927

Published: 2010

Journal Articles

Loss of Therapy-Induced Senescence in Myc-Driven Lymphomas Compromises Treatment Outcome In Vivo.

Jan Dörr, Yong Yu, Christoph Loddenkemper, MD, PhD, Ulrich Keller, MD, Andreas Buck, Bernd Dörken, Clemens Schmitt, MD

Blood (2009) 114 (22): 1686.

https://doi.org/10.1182/blood.V114.22.1686.1686

Published: 2009

Journal Articles

Role of Senescence in Dynamic Tumor/Host Responses to Cancer Therapy In Vivo.

Jan Dörr, Maja Milanovic, Christoph Loddenkemper, MD, PhD, Dido Lenze, Yong Yu, Bernd Dörken, Clemens Schmitt, MD

Blood (2009) 114 (22): 928.

https://doi.org/10.1182/blood.V114.22.928.928

Published: 2009

Journal Articles

Immunisation against Human c-MYC Elicits a T-Cell Response and Influences Growth of High Grade B-Cell Lymphoma in Mice.

Florian Helm, Andrea Wilke, Thomas Kammertoens, PhD, Christian Friese, Josef Mautner, PhD, Christoph Loddenkemper, MD, PhD, Georg Bornkamm, MD, PhD, Armin Gerbitz, MD, PhD

Blood (2009) 114 (22): 5120.

https://doi.org/10.1182/blood.V114.22.5120.5120

Published: 2009

Journal Articles

Apoptotic Lymphoma Cells Evoke a Pro-Senescent Stromal Signal That Limits Lymphoma Development.

Maurice Reimann, Soyoung Lee, Christoph Loddenkemper, MD, PhD, Jan Dörr, Vedrana Tabor, Harald Stein, MD, Bernd Dörken, Thomas Jenuwein, Clemens Schmitt, MD

Blood (2009) 114 (22): 2392.

https://doi.org/10.1182/blood.V114.22.2392.2392

Published: 2009

Journal Articles

Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group

Olaf Determann, Eva Hoster, German Ott, Heinz Wolfram Bernd, Christoph Loddenkemper, Martin Leo Hansmann, Thomas E. F. Barth, Michael Unterhalt, Wolfgang Hiddemann, Martin Dreyling, Wolfram Klapper

Blood (2008) 111 (4): 2385–2387.

https://doi.org/10.1182/blood-2007-10-117010

Published: 2008

Journal Articles

Patients Receiving IL-2 Activated Donor NK Cells Show Lower Incidence of Severe GvHD after Haploidentical SCT.

Chiara Gentilini, MD, Urte Hilbers, Volker Huppert, Christoph Loddenkemper, MD, Arne Müßig, MD, Constanze Kliem, MD, Thoralf Lange, MD, Nadezda Basara, Marcus Uhrberg, Eckhard Thiel, Dietger W. Niederwieser, Lutz Uharek

Blood (2007) 110 (11): 354.

https://doi.org/10.1182/blood.V110.11.354.354

Published: 2007

Journal Articles

The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo

Maurice Reimann, Christoph Loddenkemper, Cornelia Rudolph, Ines Schildhauer, Bianca Teichmann, Harald Stein, Brigitte Schlegelberger, Bernd Dörken, Clemens A. Schmitt

Blood (2007) 110 (8): 2996–3004.

https://doi.org/10.1182/blood-2007-02-075614

Published: 2007

Includes: Supplemental data

Journal Articles

Inactivation of the Myc−Induced DNA Damage Response Promotes Lymphomagenesis and Treatment Resistance In Vivo.

Maurice Reimann, PhD, Christoph Loddenkemper, M.D., Cornelia Rudolph, Ph.D., Harald Stein, M.D., Brigitte Schlegelberger, M.D., Bernd Dorken, M.D., Clemens A. Schmitt, M.D.

Blood (2006) 108 (11): 774.

https://doi.org/10.1182/blood.V108.11.774.774

Published: 2006

Journal Articles

Mucosal but not peripheral FOXP3 + regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART

Hans-Jörg Epple, Christoph Loddenkemper, Desirée Kunkel, Hanno Tröger, Jochen Maul, Verena Moos, Erika Berg, Reiner Ullrich, Jörg-Dieter Schulzke, Harald Stein, Rainer Duchmann, Martin Zeitz, Thomas Schneider

Blood (2006) 108 (9): 3072–3078.

https://doi.org/10.1182/blood-2006-04-016923

Published: 2006

Journal Articles

CCR7 deficiency causes ectopic lymphoid neogenesis and disturbed mucosal tissue integrity

Uta E. Höpken, Antje M. Wengner, Christoph Loddenkemper, Harald Stein, Markus M. Heimesaat, Armin Rehm, Martin Lipp

Blood (2006) 109 (3): 886–895.

https://doi.org/10.1182/blood-2006-03-013532

Published: 2006

Includes: Supplemental data

NARROW

Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice

Tumor Cell Proliferation (Ki-67 Index) Overcomes Cytology and Growth Pattern As Prognostic Factor in Mantle-Cell Lymphoma – Results from Randomized Trials of the European MCL Network

Splenic proliferative lymphoid nodules distinct from germinal centers are sites of autoantigen stimulation in immune thrombocytopenia

Cell Proliferation (Ki-67) As Prognostic Marker in Mantle Cell Lymphoma.

Lack of Foxp3 + macrophages in both untreated and B16 melanoma-bearing mice

Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation

Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation

Steady-state generation of mucosal IgA + plasmablasts is not abrogated by B-cell depletion therapy with rituximab

CD19 as Foreign Antigen Elicits a Specific T-Cell Response and Mediates Rejection of High Grade B-Cell Lymphoma In Mice

Stromal Cross-Presentation and Host Interferon-γ Signaling and Are Required for Elimination of Antigen-Loss Variants of High-Grade B Cell Lymphomas: Implications for Adoptive T Cell Therapy

Loss of Therapy-Induced Senescence in Myc-Driven Lymphomas Compromises Treatment Outcome In Vivo.

Role of Senescence in Dynamic Tumor/Host Responses to Cancer Therapy In Vivo.

Immunisation against Human c-MYC Elicits a T-Cell Response and Influences Growth of High Grade B-Cell Lymphoma in Mice.

Apoptotic Lymphoma Cells Evoke a Pro-Senescent Stromal Signal That Limits Lymphoma Development.

Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group

Patients Receiving IL-2 Activated Donor NK Cells Show Lower Incidence of Severe GvHD after Haploidentical SCT.

The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo

Inactivation of the Myc−Induced DNA Damage Response Promotes Lymphomagenesis and Treatment Resistance In Vivo.

Mucosal but not peripheral FOXP3 + regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART

CCR7 deficiency causes ectopic lymphoid neogenesis and disturbed mucosal tissue integrity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only